![](/img/cover-not-exists.png)
The novel protein homeostatic modulator BTX306 is active in myeloma and overcomes bortezomib and lenalidomide resistance
Zou, Jianxuan, Jones, Richard J., Wang, Hua, Kuiatse, Isere, Shirazi, Fazal, Manasanch, Elisabet E., Lee, Hans C., Sullivan, Robert, Fung, Leah, Richard, Normand, Erdman, Paul, Torres, Eduardo, Hecht,Journal:
Journal of Molecular Medicine
DOI:
10.1007/s00109-020-01943-6
Date:
July, 2020
File:
PDF, 4.59 MB
2020